First, the primary goal of the scholarly research was to measure the interindividual variability of medication concentrations in clinical practice, in support of few individuals developed treatment failure or drug-related toxicity through the follow-up

First, the primary goal of the scholarly research was to measure the interindividual variability of medication concentrations in clinical practice, in support of few individuals…

Anti-PD1 and anti-PDL1 mAbs such as nivolumab, pembrolizumab, or atezolizumab have proven superior efficacy over standard-of-care therapy in a variety of indications such as melanoma, non-small-cell lung cancer (NSCLC), bladder cancer, as well as others [37C42]

Anti-PD1 and anti-PDL1 mAbs such as nivolumab, pembrolizumab, or atezolizumab have proven superior efficacy over standard-of-care therapy in a variety of indications such as melanoma,…